论文部分内容阅读
Moxifloxacin是一种用于大多数呼吸道病原体感染的新的广谱抗菌素。 Moxifloxacin具有极佳的生物利用度、长的半衰期及良好的组织渗透力等药物动力学特性 ,因而其 90 %的最低抑菌浓度 (MIC90 )值通常低于标准药物剂量40 0 mg30 h的血液和肺组织中的浓度值。本文对 Moxi-floxaci
Moxifloxacin is a new broad-spectrum antibiotic used in the treatment of most respiratory pathogens. Moxifloxacin has pharmacokinetic properties such as excellent bioavailability, long half-life and good tissue penetration, so its 90% MIC90 value is usually lower than that of the standard drug dose of 40 mg30 h Concentration in lung tissue. This article on Moxi-floxaci